Safety Study of MG1102 in Patients With Solid Tumors

Update Il y a 4 ans
Reference: NCT01809912

Woman and Man

Extract

To investigate the safety and tolerability of a 28 day course of intravenous (IV) MG1102 in patients with solid tumors for which no standard therapy is available.


Inclusion criteria

  • Solid Tumors

Links